Director Dealing and LTIP Awards

26 June 2015

Synergy Health plc ("Synergy", the "Company", or the "Group")

Director Dealing and LTIP Awards

Further to the announcements released earlier today, the Company confirms that:

a) The shares acquired by Richard Steeves, Gavin Hill and Adrian Coward are subject to the irrevocable undertakings provided by each of them in respect of the Recommended Combination of the Company with STERIS Corporation. Following those acquisitions the irrevocable undertakings given by Synergy directors and their connected persons in relation to the Recommended Combination now relate to a total of 672,611 Synergy shares, amounting to 1.14 per cent. of the total issued share capital of the Company; and,

b) The vesting of all of the LTIP and Co-Invest options issued by the Company on 26 June 2015 will be time apportioned should the Recommended Combination with STERIS Corporation proceed.

For further information:

Jon Turner, Group Company Secretary +44 (0) 1793 891 893